Literature DB >> 2173245

Reproduction of mucosal disease with cytopathogenic bovine viral diarrhoea virus selected in vitro.

V Moennig1, H R Frey, E Liebler, J Pohlenz, B Liess.   

Abstract

Isolates of non-cytopathogenic bovine viral diarrhoea (BVD) virus from 18 persistently infected calves from one herd were compared by using monoclonal antibodies directed against the major viral glycoprotein gp53. All the isolates displayed an almost identical reaction pattern. Based on this antigenic analysis three cytopathogenic BVD and three non-cytopathogenic BVD viruses closely related to the non-cytopathogenic BVD herd isolate were selected. Six of the persistently infected calves were inoculated with a pool of the three closely related cytopathogenic BVD viruses and two with a pool of the three non-cytopathogenic BVD viruses. In addition three animals were infected with one closely related cytopathogenic BVD strain (Indiana) and two animals with the antigenetically different cytopathogenic BVD viral strain A1138/69. Regardless of the inoculation route all the animals superinfected with closely related cytopathogenic BVD viruses developed the characteristic lesions of mucosal disease within 14 days of infection. Animals which were inoculated with non-cytopathogenic BVD viruses which closely resembled the herd isolate, or with cytopathogenic BVD viruses which did not resemble the herd isolate did not develop any signs of disease. However, the latter group produced antibodies to the superinfecting virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173245

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  13 in total

1.  CRISPR/Cas9-Mediated Knockout of DNAJC14 Verifies This Chaperone as a Pivotal Host Factor for RNA Replication of Pestiviruses.

Authors:  O Isken; A Postel; B Bruhn; E Lattwein; P Becher; N Tautz
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

2.  Correlation between point mutations in NS2 and the viability and cytopathogenicity of Bovine viral diarrhea virus strain Oregon analyzed with an infectious cDNA clone.

Authors:  B M Kümmerer; G Meyers
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Expression of a 50 kDa putative receptor for bovine viral diarrhea virus in bovine fetal tissues.

Authors:  L Zheng; S Zhang; W Xue; S Kapil; H C Minocha
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

4.  RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease.

Authors:  P Becher; M Orlich; H J Thiel
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Cytopathogenicity of a pestivirus correlates with a 27-nucleotide insertion.

Authors:  N Tautz; G Meyers; R Stark; E J Dubovi; H J Thiel
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  A severe outbreak of mucosal disease in central Alberta.

Authors:  S C Lee; I E Borgmann; N A Gobin
Journal:  Can Vet J       Date:  1994-10       Impact factor: 1.008

7.  Pathogenesis of primary respiratory disease induced by isolates from a new genetic cluster of bovine viral diarrhea virus type I.

Authors:  C Baule; G Kulcsár; K Belák; M Albert; C Mittelholzer; T Soós; L Kucsera; S Belák
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Viral sequence insertions and a novel cellular insertion in the NS2 gene of cytopathic isolates of bovine viral diarrhea virus as potential cytopathogenicity markers.

Authors:  Adám Bálint; Vilmos Pálfi; Sándor Belák; Claudia Baule
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

Review 9.  Bovine viral diarrhea virus: biotypes and disease.

Authors:  D Deregt; K G Loewen
Journal:  Can Vet J       Date:  1995-06       Impact factor: 1.008

10.  Pathogenesis of mucosal disease: a cytopathogenic pestivirus generated by an internal deletion.

Authors:  N Tautz; H J Thiel; E J Dubovi; G Meyers
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.